Extracorporeal Membrane Oxygenation Machine (ECMO) Market Thumbnail Image

2024

Extracorporeal Membrane Oxygenation Machine (ECMO) Market

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Size, Share, Competitive Landscape and Trend Analysis Report, by Type, by Components, by Application : Global Opportunity Analysis and Industry Forecast, 2024-2033

LS : Other

Select an option
Author's: NA | Roshan Deshmukh
Publish Date:

Get Sample to Email

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Research, 2033

The global extracorporeal membrane oxygenation machine (ECMO) market was valued at $504.2 million in 2023, and is projected to reach $793.7 million by 2033, growing at a CAGR of 4.6% from 2024 to 2033. The increasing prevalence of conditions such as chronic obstructive pulmonary disease (COPD) , heart failure, and acute respiratory distress syndrome (ARDS) necessitates advanced life-support technologies like ECMO thus driving the growth of the ECMO machine market.

Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market

Market Introduction and Definition 

Patients whose hearts and lungs are unable to sustain adequate gas exchange or perfusion to preserve life can receive prolonged cardiac and respiratory support via extracorporeal membrane oxygenation (ECMO) , a life-supporting therapy. In order to enable artificial red blood cell oxygenation and carbon dioxide elimination, ECMO functions by momentarily withdrawing blood from the body. The heart and lungs may rest and repair because the ECMO machine momentarily takes over their functions. The rising incidence of severe cardiac and respiratory conditions, such as acute respiratory distress syndrome (ARDS) , chronic obstructive pulmonary disease (COPD) , and heart failure, necessitates advanced life support systems like ECMO. It provides critical support for patients with life-threatening heart and lung failure, also allows time for recovery from severe conditions and can be used as a bridge to further treatments, such as transplant. 

Key Takeaways 

  • The ECMO machine market size study covers 20 countries. The research includes a segment analysis of each country in terms of value ($Million) for the projected period 2023-2032. 
  • More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major extracorporeal membrane oxygenation machine market participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights. 
  • The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives thereby, boosting ECMO machine market opportunity.

Key Market Dynamics 

The market for extracorporeal membrane oxygenation (ECMO) machines is significantly influenced by the rising incidence of severe cardiac and respiratory conditions, such as acute respiratory distress syndrome (ARDS) , chronic obstructive pulmonary disease (COPD) , and heart failure, which necessitates advanced life support systems like ECMO. Thus, such factors boost the ECMO machine market growth.

The safety and efficacy of ECMO machines are improved by ongoing technological advancements in oxygenators, biocompatible materials, and user-friendly interfaces and are also the ECMO machine market trends. ECMO machines are now more widely available for usage in a variety of therapeutic contexts, such as field hospitals and patient transport, because of advancements in portability and miniaturisation. As the population of elderly individuals increases, so does their vulnerability to severe cardiopulmonary disorders, which highlights the necessity for ECMO support in the management of these age-related health problems. 

Patent Analysis, 2015-2024 

Although the ECMO machine market share growth has been more rapid in recent years, the industry can draw on the patents filed by various companies across various countries. For instance, patents filed by China dominated the same with a 45.5% share, the U.S. holds a share of about 9.1% and the Patent Cooperation Treaty (PCT) holds a share of about 20.5%. 

Extracorporeal Membrane Oxygenation Machine (ECMO) Market by

Market Segmentation 

The ECMO machine market analysis is segmented on the basis of type, component, application, and region. Based on type, the market is classified into veno-arterial, veno-venous, and arterio-venous. As per component, the market is classified into pumps, oxygenator, controllers, and others. Based on application, the market is classified into adult, pediatric, and neonates. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

Regional/Country Market Outlook 

North America accounted for a major ECMO machine market size market owing to the presence of several major players, availability of advanced healthcare facilities; and high healthcare infrastructure expenditure by the government organizations in the region which drive the growth of the market.?Moreover, this is attributed to the rise in incidences of chronic diseases, and the strong presence of key market players in the region. 

Asia-Pacific ECMO machine market share is estimated to grow with the highest CAGR during the forecast period, owing to enhancements in healthcare facilities, increase in prevalence of chronic diseases, surge in awareness about early disease diagnosis, and increase in healthcare expenditure. In addition, this region offers lucrative opportunities for the extracorporeal membrane oxygenation (ECMO) machine market key players, owing to a rising awareness of advanced medical technologies. Companies are focusing on this region to expand their market presence. 

Industry Trends

  • Innovations leading to smaller, portable ECMO systems that can be used outside traditional ICU settings, including during patient transport and in emergency situations. 
  • Incorporation of digital health technologies, such as remote monitoring, data analytics, and artificial intelligence, to improve patient management and outcomes. 

Competitive Landscape 

The major players operating in the extracorporeal membrane oxygenation (ECMO) machine market are Medtronic Plc, Sorin Group, Terumo Corporation, MAQUET Holding, Nipro Medical Corporation, Microport Scientific Corporation, Medos Medizintechnik AG, Getinge AB, Livanova Plc, and Fresnius Medical Care. 

Recent Developments 

  • In November 2022, LivaNova PLC a market-leading medical technology and innovation company, announced it received 510 (k) clearance for extracorporeal membrane oxygenation (ECMO) from the U.S. Food and Drug Administration (FDA) for LifeSPARC, the Company’s next-generation Advanced Circulatory Support (ACS) pump and controller system. 
  • In July 11, 2022, Inspira Technologies OXY B.H.N. Ltd. announced the "Liby" System, an advanced form of life support the extracorporeal membrane oxygenation (ECMO) machine, used to treat patients with life-threatening heart and lung failure. 

Key Sources Referred 

  • National Center for Biotechnology Information 
  • World Health Organization (WHO)  
  • National Library of Medicine 
  • The United States Food and Drug Administration 
  • U.S. Department of Health & Human Services 
  • Centers for Disease Control and Prevention 
  • Australian Institute of Health and Welfare 
  • Johns Hopkins Medicine 
  • National Centre for Disease Control (NCDC)  
  • American Heart Association, Inc. 
  • NHS Blood and Transplant 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the  extracorporeal membrane oxygenation machine market from 2024 to 2033 to identify the prevailing extracorporeal membrane oxygenation machine market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the ECMO machine industry players segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the ECMO machine industry players.
  • The report includes the analysis of the regional as well as global ECMO machine market forecast, key players, market segments, application areas, and market growth strategies.

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Report Highlights

Aspects Details
icon_1
Market Size By 2033

USD 793.7 Million

icon_2
Growth Rate

CAGR of 4.6%

icon_3
Forecast period

2024 - 2033

icon_4
Report Pages

280

icon_5
By Type
  • Veno-arterial
  • Veno-venous
  • Others
icon_6
By Components
  • Pumps
  • Oxygenator
  • Controllers
  • Others
icon_7
By Application
  • Adult
  • Pediatric
  • Neonates
icon_8
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_9
Key Market Players

Microport Scientific Corporation, Nipro Medical Corporation, Fresnius Medical Care, GETINGE AB, Medtronic Plc, Terumo Corporation, Sorin Group, Medos Medizintechnik AG, Livanova Plc, MAQUET Holding

Author Name(s) : NA | Roshan Deshmukh
Related Tags
Frequently Asked Questions?

Surge in the prevalence of cardiopulmonary disease is the upcoming trends of Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market

Adult is the leading application of Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market

North America is the largest regional market for Medical Extracorporeal Membrane Oxygenation Machine (ECMO)

The extracorporeal membrane oxygenation (ECMO) machine market was valued at $504.23 million in 2023 and is estimated to reach $793.60 million by 2033, exhibiting a CAGR of 4.1% from 2024 to 2033.

The major players operating in the extracorporeal membrane oxygenation (ECMO) machine market are Medtronic Plc, Sorin Group, Terumo Corporation, MAQUET Holding, Nipro Medical Corporation, Microport Scientific Corporation, Medos Medizintechnik AG, Getinge AB, Livanova Plc, and Fresnius Medical Care.

Asia-Pacific is the fastest growing regional market for Medical Extracorporeal Membrane Oxygenation Machine (ECMO)

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Extracorporeal Membrane Oxygenation Machine (ECMO) Market

Global Opportunity Analysis and Industry Forecast, 2024-2033